• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 57
  • 31
  • 30
  • 13
  • Tagged with
  • 131
  • 88
  • 51
  • 43
  • 40
  • 39
  • 39
  • 38
  • 34
  • 33
  • 31
  • 19
  • 19
  • 15
  • 15
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
121

Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations / Hohe Lebenserwartung bei Kindern und Jugendlichen mit fortgeschrittenen Erkrankungen nach ein/mehrfach autologer und HLA-identer/teilweise identer allogener Stammzelltransplantation

Niederwieser, Christian 30 November 2016 (has links) (PDF)
Purpose: We determined the indication, outcome and risk factors of single and multiple hematopoietic stem cell transplantation(s) (HSCT) in children and adolescents mostly with advanced disease. Methods: Forty-one out of 483 patients (8.5%; median age 9 years) diagnosed at the University of Leipzig with haematological and oncological diseases required HSCT from 1999 to 2011. Results: Patients had overall survival (OS) of 63±10% and 63±16%, event-free survival (EFS) of 57±10% and 42±16%, relapse incidence (RI) of 39±10% and 44±18% and non-relapse mor-tality (NRM) of 4±4% and 13±9% at 10-years after one or more HSCT for allogeneic and autologous HSCT, respectively. One patient in complete remission (CR)1 and five with advanced disease received two HSCT. Four of the six patients maintained/achieved CR for a median of 13 months. Three died of progression and one of NRM. Two patients had a third HSCT and one survived in CR +231 days after HSCT. Risk factors for OS and EFS were disease stage at HSCT and EBMT risk-score. Center (paediatric or JACIE accredited paediatric/adult) was not a determinant for survival. Conclusion: Paediatric single and multiple HSCT are important curative approaches for high-risk malignant diseases with low NRM. Efforts to reduce high RI remain the major aim.
122

Onkogenomische Aspekte Zytokin-assoziierter Signaltransduktion / Oncogenomic aspects of cytokine-associated signal transduction

Schoof, Nils 21 October 2008 (has links)
No description available.
123

Die Bedeutung von Stanniocalcin 2 im humanen Neuroblastom / Relevance of Stanniocalcin 2 in human Neuroblastoma

Volland, Sonja 21 January 2009 (has links)
No description available.
124

Mechanismen der Durchbrechung der sekundären Antiöstrogenresistenz durch GnRH-Analoga in Mammakarzinomzellen / Mechanisms of breaking the secondary antiestrogen resistance with GnRH analogs in breast cancer cells

Block, Martin 23 October 2009 (has links)
No description available.
125

Einfluss von GnRH Analoga auf die Metastasierung humaner Mammakarzinomzellen in vitro und in vivo / Effect of GnRH analogs on the metastasis of human breast cancer cells in vitro and in vivo

Schubert, Antje 25 October 2010 (has links)
No description available.
126

Wirkung schwerer Ionen auf strahlenresistente und strahlensensitive Tumorzellen / Effect of heavy ions upon radioresistant and radiosensitive tumor cells

Hofman-Hüther, Hana 31 October 2001 (has links)
No description available.
127

Expression von Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (PIN1) in Blasten von Patienten mit akuter myeloischer Leukämie / Expression of peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (PIN1) in blasts of patients with acute myeloid leukemia

Hangen, Hanne 05 July 2011 (has links)
No description available.
128

Zytogenetische Grundlage der malignen Progression anaplastischer Astrozytome: Chromosomale Aberrationen von Primärtumoren, Rezidiven und ihr Einfluss auf das Überleben / Cytogenetic basics of malignant progression of anaplastic astrocytoma: Chromosomal aberrations of primary and recurrent tumors and their influence on survival

Haupt, Jörn 02 November 2011 (has links)
No description available.
129

Medical domain knowledge in domain-agnostic generative AI

Kather, Jakob Nikolas, Ghaffari Laleh, Narmin, Foersch, Sebastian, Truhn, Daniel 31 May 2024 (has links)
The text-guided diffusion model GLIDE (Guided Language to Image Diffusion for Generation and Editing) is the state of the art in text-to-image generative artificial intelligence (AI). GLIDE has rich representations, but medical applications of this model have not been systematically explored. If GLIDE had useful medical knowledge, it could be used for medical image analysis tasks, a domain in which AI systems are still highly engineered towards a single use-case. Here we show that the publicly available GLIDE model has reasonably strong representations of key topics in cancer research and oncology, in particular the general style of histopathology images and multiple facets of diseases, pathological processes and laboratory assays. However, GLIDE seems to lack useful representations of the style and content of radiology data. Our findings demonstrate that domain-agnostic generative AI models can learn relevant medical concepts without explicit training. Thus, GLIDE and similar models might be useful for medical image processing tasks in the future - particularly with additional domain-specific fine-tuning.
130

Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations: Favorable outcome in children and adolescents with a high proportion of advanced phase disease usingsingle/multiple autologous or matched/mismatchedallogeneic stem cell transplantations

Niederwieser, Christian 10 June 2016 (has links)
Purpose: We determined the indication, outcome and risk factors of single and multiple hematopoietic stem cell transplantation(s) (HSCT) in children and adolescents mostly with advanced disease. Methods: Forty-one out of 483 patients (8.5%; median age 9 years) diagnosed at the University of Leipzig with haematological and oncological diseases required HSCT from 1999 to 2011. Results: Patients had overall survival (OS) of 63±10% and 63±16%, event-free survival (EFS) of 57±10% and 42±16%, relapse incidence (RI) of 39±10% and 44±18% and non-relapse mor-tality (NRM) of 4±4% and 13±9% at 10-years after one or more HSCT for allogeneic and autologous HSCT, respectively. One patient in complete remission (CR)1 and five with advanced disease received two HSCT. Four of the six patients maintained/achieved CR for a median of 13 months. Three died of progression and one of NRM. Two patients had a third HSCT and one survived in CR +231 days after HSCT. Risk factors for OS and EFS were disease stage at HSCT and EBMT risk-score. Center (paediatric or JACIE accredited paediatric/adult) was not a determinant for survival. Conclusion: Paediatric single and multiple HSCT are important curative approaches for high-risk malignant diseases with low NRM. Efforts to reduce high RI remain the major aim.:Bibliographic description 3 Introduction: 4 Infections 6 Veno-occlusive disease (VOD) 7 Graft rejection 7 Graft-versus Host Disease (GvHD) 8 Non-relapse mortality (NRM) 9 Relapse of the underling disease 9 Indications for HSCT 10 HSCT in Children. 10 Research questions: 12 Publication 13 Discussion 22 Future developments 25 References 26 Abbreviations 28 Summary 29 Zusammenfassung 33 Erklärung über die eigenständige Abfassung der Arbeit 38 Curriculum vitae 39 Acknowledgement 42

Page generated in 0.052 seconds